Business Wire

FL-KNOWBE4

1.12.2021 14:02:14 CET | Business Wire | Press release

Share
KnowBe4’s Team of Cybersecurity Experts Release Predictions for 2022

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced its 2022 cybersecurity predictions from its team of industry experts.

The predicted cybersecurity trends for 2022 include:

  • Nuclear Ransomware 3.0
    A trend that is currently building for the future on the side of the bad actor is that ransomware gangs are morphing into "everything gangs." Instead of just doing ransomware and data exfiltration, they are doing cryptomining, botnet creation, DDoS attacks, etc. The attack gangs of the future will look at every new victim as a pot of gold and try to figure out what to do and in which order to maximize financial value extraction.
  • New Malware Family: Not the Kind You Would Welcome Into Your Home
    A new dangerous and persistent metamorphic malware family called “Tardigrade” is a new strain of Windows malware. It can constantly adapt to avoid detection and was first found targeting the biotech industry, including the infrastructure behind vaccine manufacturing, according to security researchers. This “metamorphic” ability prevents the malware from leaving a consistent signature behind, making it very hard for antivirus programs to spot. It contains the sneaky ability to spread both via phishing emails and USB devices.
  • Virtually Pwned
    Meta, the brand formerly known as Facebook, will entice masses to join the Metaverse. This will spawn a rush to establish dominance in the virtual world. As a result, hackers will also be drawn into this world, and we will see virtual attacks against both individuals and organizations. We will see an explosion of bad things happen to people and resources in the virtual world…virtual looting, virtual theft, account takeovers and more creative criminal exploits.
  • Disinformation Powered by Deep Fakes Will Cause a Political/Financial Circus
    We will see a coordinated disinformation campaign that will rely heavily on deep fakes and manipulated footage to cause a political/financial circus. A deep fake could be used to manipulate a certain political party’s views by stating false opinions, promises or beliefs of a particular candidate. This could cause a chain reaction of certain organizations pulling funds from a political campaign based on statements made by the deep fake.
  • An Attack Against Cryptocurrency Will Hit Real World Economies
    A major cryptocurrency will be attacked, causing billions of dollars in lost value either through direct theft or in value loss. Many individuals and organizations will be severely impacted and it will be referred to as the Black Crypto Day.
  • A Major EU Power Station/Utility Provider Will Be Crippled in a Novel Way Other Than Ransomware
    Most likely somewhere in Eastern Europe, we will see some bad actors cut off your power, your gas and your water. Then as you watch in horror as your phone, tablets and laptop batteries die, they will hand out an olive branch that many will be ready to accept, but at what cost?
  • Someone Will Hack Back the Wrong Bad Actor and Trigger an International Incident
    An overly-eager security researcher will think they have identified the culprit behind a major attack. In an act of retaliation, they will hack back only to discover they did not attribute the attack correctly. This will cause a major international incident and the organization responsible will be placed under extreme scrutiny.
  • The Rise of Dark Economy M&A
    A lot of criminal gangs have become extremely wealthy. In fact, some shady organizations are large enough to be listed on a stock exchange. So, we will see a more formalized dark economy emerge with some M&A activity taking place as some gangs will look to cash-in by selling their organization while others look to grow in capability and reach.
  • When AI Goes Wrong In 2022
    We’ll see the first wave of intelligent attack bots. The future is good threat hunting bots versus bad bots and the best algorithm wins.

“In many ways, it seems as if things are getting worse for cybersecurity professionals who are trying their best to protect their organizations,” said Stu Sjouwerman, CEO, KnowBe4. “But I think we are starting to see more of a focus on the human element, including human behavior, of cybersecurity protection measures. This is a positive shift in direction because people can implement all of the technical tools and controls in the world, but if they do not focus their efforts on the human layer of security, they are going to run into challenges. At the end of the day, a strong security culture is what truly matters and what we will see organizations focused on as we move into 2022.”

The predicted trends were collected from KnowBe4’s global team of security awareness advocates who are experts with decades of experience in the cybersecurity field. For more information on KnowBe4’s team of experts, visit https://www.knowbe4.com/security-awareness-training-advocates .

About KnowBe4

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, is used by more than 44,000 organizations around the globe. Founded by IT and data security specialist, Stu Sjouwerman, KnowBe4 helps organizations address the human element of security by raising awareness about ransomware, CEO fraud, and other social engineering tactics through a new-school approach to awareness training on security. Kevin Mitnick, an internationally recognized cybersecurity specialist and KnowBe4's Chief Hacking Officer, helped design the KnowBe4 training based on his well-documented social engineering tactics. Tens of thousands of organizations rely on KnowBe4 to mobilize their end users as their last line of defense.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye